PT1173770E - Metodo para estimar o risco de ulcera peptica - Google Patents
Metodo para estimar o risco de ulcera pepticaInfo
- Publication number
- PT1173770E PT1173770E PT00922684T PT00922684T PT1173770E PT 1173770 E PT1173770 E PT 1173770E PT 00922684 T PT00922684 T PT 00922684T PT 00922684 T PT00922684 T PT 00922684T PT 1173770 E PT1173770 E PT 1173770E
- Authority
- PT
- Portugal
- Prior art keywords
- risk
- peptic ulcer
- phenotype
- gastritis
- estimating
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 208000008469 Peptic Ulcer Diseases 0.000 title abstract 3
- 208000011906 peptic ulcer disease Diseases 0.000 title abstract 3
- 208000007882 Gastritis Diseases 0.000 abstract 3
- 108010047320 Pepsinogen A Proteins 0.000 abstract 2
- 102400000921 Gastrin Human genes 0.000 abstract 1
- 241000589989 Helicobacter Species 0.000 abstract 1
- 239000012491 analyte Substances 0.000 abstract 1
- 108010066264 gastrin 17 Proteins 0.000 abstract 1
- GKDWRERMBNGKCZ-RNXBIMIWSA-N gastrin-17 Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)CNC(=O)[C@H]1NC(=O)CC1)C1=CC=C(O)C=C1 GKDWRERMBNGKCZ-RNXBIMIWSA-N 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
- 238000012876 topography Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/595—Gastrins; Cholecystokinins [CCK]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96472—Aspartic endopeptidases (3.4.23)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
- G01N2800/062—Gastritis or peptic ulcer disease
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Seal Device For Vehicle (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FI990992A FI118653B (fi) | 1999-04-30 | 1999-04-30 | Menetelmä peptisen haavan riskin määrittämiseksi |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1173770E true PT1173770E (pt) | 2005-09-30 |
Family
ID=8554567
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT00922684T PT1173770E (pt) | 1999-04-30 | 2000-04-28 | Metodo para estimar o risco de ulcera peptica |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6872543B1 (enExample) |
| EP (1) | EP1173770B1 (enExample) |
| JP (1) | JP4598959B2 (enExample) |
| CN (1) | CN100573152C (enExample) |
| AT (1) | ATE300053T1 (enExample) |
| AU (1) | AU4299800A (enExample) |
| DE (1) | DE60021369T2 (enExample) |
| DK (1) | DK1173770T3 (enExample) |
| ES (1) | ES2241597T3 (enExample) |
| FI (1) | FI118653B (enExample) |
| PT (1) | PT1173770E (enExample) |
| RU (1) | RU2225615C2 (enExample) |
| WO (1) | WO2000067035A1 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI20010019L (fi) * | 2001-01-05 | 2002-07-06 | Biohit Oyj | Menetelmä atrofisen diagnostisoimiseksi |
| AU2002252456A1 (en) * | 2001-03-23 | 2002-10-08 | Aphton Corporation | Combination treatment of pancreatic cancer |
| US20090191232A1 (en) * | 2001-05-04 | 2009-07-30 | Gevas Philip C | Combination therapy for the treatment of tumors |
| US20030021786A1 (en) * | 2001-07-09 | 2003-01-30 | Gevas Philip C. | Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus |
| SE0200974D0 (sv) * | 2002-03-27 | 2002-03-27 | Phagen Ab | Screening method for gastritis |
| FI119571B (fi) * | 2002-09-06 | 2008-12-31 | Biohit Oyj | Menetelmä esofagiitin tai Barrettin ruokatorven riskin osoittamiseksi yksilöllä |
| KR20050118690A (ko) * | 2003-03-28 | 2005-12-19 | 애프톤 코포레이션 | 가스트린 호르몬 면역어세이 |
| FI119572B (fi) * | 2004-03-05 | 2008-12-31 | Biohit Oyj | Menetelmä vatsan limakalvon tilan ennustamiseksi |
| CA2561405C (en) * | 2004-03-29 | 2014-01-21 | Receptor Biologix, Inc. | Monoclonal antibodies to gastrin hormone |
| DK1794586T3 (da) | 2004-09-22 | 2013-05-13 | Cancer Advances Inc | Monoklonale antistoffer til progastrin |
| WO2007007333A2 (en) * | 2005-07-12 | 2007-01-18 | Technion Research And Development Foundation Ltd. | System and method for active detection of asymmetry in rotating structures |
| CN101910844A (zh) * | 2007-10-26 | 2010-12-08 | 拜奥希特公司 | 用于诊断与萎缩性胃炎相联系的自身免疫性疾病和胃癌的方法和产品 |
| RU2465597C1 (ru) * | 2011-04-08 | 2012-10-27 | Сергей Михайлович Котелевец | Способ определения вероятности развития рака желудка |
| RU2582565C1 (ru) * | 2015-03-06 | 2016-04-27 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Оренбургский государственный медицинский университет" Министерства здравоохранения Российской Федерации /ГБОУ ВПО ОрГМУ Минздрава России/ | Способ дифференциальной диагностики язвы желудка и двенадцатиперстной кишки |
| CN104820096B (zh) * | 2015-04-30 | 2017-04-19 | 必欧瀚生物技术（合肥）有限公司 | 一种判断早期胃癌风险检测用标志物的量的联合标准量及在筛查早期胃癌方面的应用 |
| CN107271669A (zh) * | 2016-09-23 | 2017-10-20 | 清华大学深圳研究生院 | 胃蛋白酶原、抗幽门螺杆菌抗体和胃泌素17检测方法及其试剂盒 |
| CN107328938A (zh) * | 2016-09-23 | 2017-11-07 | 清华大学深圳研究生院 | 胃蛋白酶原和抗幽门螺杆菌抗体检测方法及其试剂盒 |
| JP6885581B2 (ja) * | 2017-02-06 | 2021-06-16 | 学校法人東京歯科大学 | ガストリン測定におけるカットオフ値の推定方法 |
| EP3624841A4 (en) | 2017-06-15 | 2021-01-27 | Cancer Advances, Inc., | COMPOSITIONS AND METHODS FOR INDUCING HUMORAL AND CELLULAR IMMUNITIES AGAINST TUMORS AND CANCER |
| US12150978B2 (en) | 2017-06-15 | 2024-11-26 | Cancer Advances Inc. | Compositions and methods for preventing tumors and cancer |
| RU2677228C1 (ru) * | 2017-12-08 | 2019-01-16 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Национальный исследовательский Мордовский государственный университет им. Н.П. Огарёва" | Способ иммунодиагностики заболеваний гастродуоденальной зоны |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07304800A (ja) * | 1994-05-06 | 1995-11-21 | Nippon Igaku Rinshiyou Kensa Kenkyusho:Kk | ヒトペプシノゲンに対するモノクローナル抗体 |
| FI97304C (fi) | 1994-11-16 | 1996-11-25 | Locus Genex Oy | Menetelmä mahasyövän riskin seulonnaksi |
| JP2949474B2 (ja) * | 1995-08-28 | 1999-09-13 | 隆久 古田 | ペプシノーゲンｉ／ｉｉ比の変化率を基礎としたヘリコバクター・ピロリ除菌判定方法 |
| JPH10148636A (ja) * | 1996-11-15 | 1998-06-02 | Takahisa Furuta | ペプシノーゲン ｉ／ｉｉ 比の変化率を基礎としたヘリコバクター・ピロリ除菌判定方法 |
-
1999
- 1999-04-30 FI FI990992A patent/FI118653B/fi active IP Right Grant
-
2000
- 2000-04-28 WO PCT/FI2000/000377 patent/WO2000067035A1/en not_active Ceased
- 2000-04-28 PT PT00922684T patent/PT1173770E/pt unknown
- 2000-04-28 US US09/959,551 patent/US6872543B1/en not_active Expired - Lifetime
- 2000-04-28 AU AU42998/00A patent/AU4299800A/en not_active Abandoned
- 2000-04-28 RU RU2001132335/15A patent/RU2225615C2/ru active
- 2000-04-28 AT AT00922684T patent/ATE300053T1/de not_active IP Right Cessation
- 2000-04-28 JP JP2000615822A patent/JP4598959B2/ja not_active Expired - Lifetime
- 2000-04-28 ES ES00922684T patent/ES2241597T3/es not_active Expired - Lifetime
- 2000-04-28 CN CN00808720.2A patent/CN100573152C/zh not_active Expired - Lifetime
- 2000-04-28 DK DK00922684T patent/DK1173770T3/da active
- 2000-04-28 EP EP00922684A patent/EP1173770B1/en not_active Expired - Lifetime
- 2000-04-28 DE DE60021369T patent/DE60021369T2/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1173770B1 (en) | 2005-07-20 |
| DE60021369D1 (de) | 2005-08-25 |
| FI990992L (fi) | 2000-10-31 |
| DE60021369T2 (de) | 2006-05-24 |
| DK1173770T3 (da) | 2005-08-08 |
| EP1173770A1 (en) | 2002-01-23 |
| ES2241597T3 (es) | 2005-11-01 |
| ATE300053T1 (de) | 2005-08-15 |
| RU2225615C2 (ru) | 2004-03-10 |
| CN1355888A (zh) | 2002-06-26 |
| CN100573152C (zh) | 2009-12-23 |
| JP4598959B2 (ja) | 2010-12-15 |
| FI118653B (fi) | 2008-01-31 |
| FI990992A0 (fi) | 1999-04-30 |
| JP2002543433A (ja) | 2002-12-17 |
| WO2000067035A1 (en) | 2000-11-09 |
| US6872543B1 (en) | 2005-03-29 |
| AU4299800A (en) | 2000-11-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1173770E (pt) | Metodo para estimar o risco de ulcera peptica | |
| WO2003043487A3 (en) | Method of using a non-antibody protein to detect and measure an analyte | |
| WO2002040998A3 (de) | Kit und verfahren zur multianalytbestimmung | |
| DE60332639D1 (de) | Verwendung von biomarkern zum nachweis von eierstockkrebs | |
| DE60228557D1 (de) | Candida-nachweis | |
| EP1379693A4 (en) | BIO STICK CODES BASED ON OLIGONUCLEOTIDE-MODIFIED PARTICLES | |
| WO2002054084A8 (en) | A method for diagnosing atrophic gastritis | |
| DE69937835D1 (de) | Antikörper für apoptosemarker und anwendungsverfahren | |
| DK1513878T3 (da) | Sammensætninger og fremgangsmåder til analyse af Apo B48 og Apo B100 | |
| ATE370414T1 (de) | Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs | |
| RU2001132335A (ru) | Способ оценки наличия риска пептической язвы, включающий в себя этапы количественного определения концентрации пепсиногена i (pgi) и гастрин-17 в образце сыворотки | |
| WO2003083490A3 (en) | Method for predicting antiphospholid syndrome | |
| ATE478337T1 (de) | Methoden zum nachweis analyten in proben | |
| PT918991E (pt) | Metodo de ensaio | |
| AU2003260530A1 (en) | Method for detecting a risk of acid related disease in an individual | |
| DE69942215D1 (de) | Verfahren zum immunochemischen Testen des Anti-HM1.24-Antikörpers | |
| DK1090297T3 (da) | Fremgangsmåde til påvisning af et antistof i en væskepröve | |
| ATE466884T1 (de) | Holo-transcobalamin bindungspartner und ihre verwendung in cobalamintest | |
| CY1109461T1 (el) | Βελτιωμενες μεθοδοι ανοσολογικου προσδιορισμου | |
| WO2003027656A3 (en) | Electrochemical control of the redox environment for the analysis of a sample | |
| ATE421093T1 (de) | Schnelle bestimmung verschiedener formen von hgf (heptocyte growth factor) in den körperflüssigkeiten | |
| ATE412181T1 (de) | Verbessertes verfahren zur diagnose des akuten koronarsyndroms | |
| ATE339683T1 (de) | Verfahren zur detektion und konzentrationsbestimmung von schwefelfreien odoriermitteln in erd- oder brenngas | |
| FI990991A0 (fi) | Menetelmä irreversiibeleille neurovahingoille riskialttiin yksikön identifioimiseksi | |
| DE59910326D1 (de) | Verwendung derivatisierter Reagenzien in Chemilumineszenz- und Elektrochemilumineszenz-Nachweisverfahren |